EML4 and non-small cell lung carcinoma: Zhao et al. found that EML4-ALK fusion gene is significantly higher in patients with III-IV stage NSCLC than with I-II stage NSCLC [58] and in patients with brain metastases, the fusion may occur in 3–7% patients [55].